Comprehensive Ayurvedic Management of Treatment Resistant Major Depressive Disorder: A Case Report
DOI:
https://doi.org/10.70066/jahm.v14i3.2628Keywords:
Ayurveda, Case Report, Major Depressive disorder, UnmadaAbstract
Background: Major Depressive Disorder (MDD), a frequently found severe psychiatric condition which leads to significant impairment in mood, cognition, daily functioning as well as overall quality-of-life. Features include depressed mood, loss-of-interest, feelings of worthlessness, guilt and reduced sleep. In Ayurveda, such conditions parallel with Kaphaja unmada involving vata and tama dosha. Clinical Findings: A 21-year-old-male presented with chief complaints of low mood, loss-of-interest, feeling of worthlessness, hopelessness, suicidal thoughts, feeling guilty and reduced sleep. His general appearance was poorly groomed, sad with reduced motor-activity. On examination reveals slow speech with low-pitch-voice, depressed mood with abnormal thought content. The severity was checked by assessment scales : Hamilton Depression Rating Scale (HAM-D) 32 and The Montgomery–Asberg Depression Rating Scale (MADRS) 30, reveals severe depression. Hamilton Anxiety Rating Scale (HAM-A) score 25 suggesting severe anxiety and Beck’s Hopelessness (BHS) 23 indicating moderate hopelessness. As per DSM-V-TR, diagnosed as MDD, characterized by depressed mood, loss-of-interest, feeling of worthlessness and insomnia. Intervention:Intervention encompassed comprehensive protocol spanning over 375 days with 2-in-patient admissions comprising Shodhana, External procedures, nasya along with oral medications, Satwawajayachikitsa (psychotherapy) and yoga. Outcome: Gradual improvement was observed in assessment parameters across multiple domains. HAM-D reduced to 13 from 32, MADRS reduced to 12 from 30, HAM-A reduced to 10 from 25 and BHS reduced to 8 from 13, at baseline, indicating clinical improvement in mood disturbances and anxiety. Conclusion: A chronic case of treatment-resistant severe depression with recurrent episodes, on combined therapy, showed marked improvement after comprehensive management, as assessed through HAM-D, MADRS, HAM-A and BHS domains without any adverse events. Long-term follow-up of 12 months shows sustained relief and improved daily functioning in MDD. This case explains the role of comprehensive Ayurveda protocol in the management of treatment-resistant severe depression.References
Bains N, Abdijadid S. Major Depressive Disorder. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559078/
Trifu S, Sevcenco A, Stănescu M, Drăgoi AM, Cristea MB. Efficacy of electroconvulsive therapy as a potential first-choice treatment in treatment-resistant depression (Review). Experimental and Therapeutic Medicine. 2021 Nov;22(5):1281. Available from: https://doi.org/10.3892/etm.2021.10716
DiBello JR, Xiong X, Liu X, Zhong W, Merola A, Li M, et al. Trajectories of pharmacological therapies for treatment-resistant depression: a longitudinal study. BMC Psychiatry. 2025;25:215. Available from: https://doi.org/10.1186/s12888-025-06518-8
Chand ACP, Das DD. Ayurvedic management of Kaphaja Unmada (Depression): a single case study. International Journal of AYUSH CaRe. 2025;9(1):97–101. Available from: https://doi.org/10.70805/ijacare.v9i1.684
Sarhyal A, Chate S, Tubaki BR, Thakur R. Efficacy of Brahmi vati and Aswagandharista in major depressive disorder: a randomized controlled trial. Journal of Ayurveda and Integrative Medicine. 2024 Nov-Dec;15(6):101022. Available from: https://doi.org/10.1016/j.jaim.2024.101022
Tubaki BR, Chandrashekar CR, Sudhakar D, Prabha TN, Lavekar GS, Kutty BM. Clinical efficacy of Manasamitra Vataka (an Ayurveda medication) on generalized anxiety disorder with comorbid generalized social phobia: a randomized controlled study. Journal of Alternative and Complementary Medicine. 2012 Jun;18(6):612–621. Available from: https://doi.org/10.1089/acm.2010.0778
Yadavaji Trikamji (editor). Charaka Samhita of Agnivesha, revised by Charaka and redacted by Dridhabala, with Ayurveda Dipika commentary of Chakrapani Datta, Chikitsasthana, chapter 9, verse no.25–27. Reprint edition, Varanasi; Chaukhambha Surbharati Prakashan;2017;259
Yadavaji Trikamji (editor). Charaka Samhita of Agnivesha, revised by Charaka and redacted by Dridhabala, with Ayurveda Dipika commentary of Chakrapani Datta, Kalpasthana, chapter 7, verse no.37–39. Reprint edition, Varanasi; Chaukhambha Surbharati Prakashan;2017;836
Yadavaji Trikamji (editor). Charaka Samhita of Agnivesha, revised by Charaka and redacted by Dridhabala, with Ayurveda Dipika commentary of Chakrapani Datta, Siddhi Sthana, chapter 9, verse no.116–117. Reprint edition, Varanasi; Chaukhambha Surbharati Prakashan;2017;993
Jain R, Narasimha Murthy K, Tripathi JS. Post-stroke depression and its management by Basti therapy: an overview. Journal of Ayurveda and Holistic Medicine (JAHM). 2023;11(3). Available from: https://doi.org/10.70066/jahm.v11i3.774
Valecha R, Dhingra D. Behavioral and biochemical evidences for antidepressant-like activity of Celastrus paniculatus seed oil in mice. Basic and Clinical Neuroscience. 2016 Jan;7(1):49–56. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892330/
Das R, et al. Effects of Takradhara on psycho-somatic disorders: a review. International Journal of Research in Ayurveda and Pharmacy. 2020 Sep-Oct;11(5):135–137. Available from: http://dx.doi.org/10.7897/2277-4343.1105155
Xue BX, He RS, Lai JX, Mireku-Gyimah NA, Zhang LH, Wu HH. Phytochemistry, data mining, pharmacology, toxicology and the analytical methods of Cyperus rotundus L. (Cyperaceae): a comprehensive review. Phytochemistry Reviews. 2023 May 15;1–46. Available from: https://doi.org/10.1007/s11101-023-09870-3
Pathak S, Godela R. Nardostachys jatamansi: phytochemistry, ethnomedicinal uses, and pharmacological activities: a comprehensive review. Fitoterapia. 2024 Jan;172:105764. Available from: https://doi.org/10.1016/j.fitote.2023.105764
Tandon PN. Indian Rauwolfia research led to the evolution of neuropsychopharmacology & the 2000 Nobel Prize (Part I). Indian Journal of Medical Research. 2021 Jul;154(1):163–168. Available from: https://doi.org/10.4103/ijmr.ijmr_1672_21
Mata-Bermudez A, Diaz-Ruiz A, Silva-García LR, Gines-Francisco EM, Noriega-Navarro R, Rios C, et al. Mucuna pruriens, a possible treatment for depressive disorders. Neurology International. 2024 Nov 16;16(6):1509–1527. Available from: https://doi.org/10.3390/neurolint16060112
Shirwaikar A, Ram HN, Mohapatra P. Antioxidant and antiulcer activity of aqueous extract of a polyherbal formulation. Indian Journal of Experimental Biology. 2006 Jun;44(6):474–480. Available from: [Add DOI/URL if available]
Shaik RB, Kumar S, Prasad B, Mhaiskar B. Post-traumatic generalised anxiety disorder induced secondary insomnia managed with multimodal holistic Ayurveda approach: a case report. Journal of Ayurveda and Holistic Medicine (JAHM). 2026;14(1):96–105. Available from: https://doi.org/10.70066/jahm.v14i1.2457
Prasad B, Kumari S, Patel A, Sushma D, Soni A, Prayer P. Impact of Pranayama practices on Blood Pressure in Hypertensive Adults: A Scoping Review of Emerging Evidence from Randomised Controlled Trials. Journal of Ayurveda and Holistic Medicine (JAHM). 2025;13(9):31–45. Available from: https://doi.org/10.70066/jahm.v13i9.2346
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Aayushi U Soni, Basavaraj R Tubaki, Sonali Konkeri, Bawadkar Prasad

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.